Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions

Molecular Systems Biology

Volumn 9, Issue , 2013, Pages

  Courcelles, Mathieu ^a,b   Frémin, Christophe ^a   Voisin, Laure ^a   Lemieux, Sébastien ^a,b   Meloche, Sylvain ^a,b   Thibault, Pierre ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

bioinformatics; cell signaling; MAP kinases; phosphoproteomics; phosphorylation dynamics

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEOME; PROTEOME; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; PROTEIN C JUN;

ARTICLE; BIOINFORMATICS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOSKELETON; DNA BINDING; EPITHELIUM CELL; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RNA SPLICING; ANIMAL CELL; CELL FUNCTION; CELL JUNCTION; CONTROLLED STUDY; DYNAMICS; KINETICS; NONHUMAN; PROTEIN TARGETING; QUANTITATIVE STUDY; RAT; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CYTOLOGY; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOSKELETON; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR JUNCTIONS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEINS; PROTEOME; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RNA SPLICING; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 84878628963     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2013.25     Document Type: Article

References (43)

1. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157 (Pubitemid 121007534)
2. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315
3. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M (2000) Cell cycledependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19: 2056-2068 (Pubitemid 30237581)
4. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31: 365-370 (Pubitemid 36157284)
5. Carlson SM, Chouinard CR, Labadorf A, Lam CJ, Schmelzle K, Fraenkel E, White FM (2011) Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal 4: rs11
6. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos- Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452 (Pubitemid 32531301)
7. Chiu R, Angel P, Karin M (1989) Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59: 979-986 (Pubitemid 20024609)
8. Cobb MH, Goldsmith EJ (1995) How MAP kinases are regulated. J Biol Chem 270: 14843-14846
9. Courcelles M, Lemieux S, Voisin L, Meloche S, Thibault P (2011) ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses. Proteomics 11: 2654-2671
10. Cuevas BD, Abell AN, Johnson GL (2007) Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26: 3159-3171 (Pubitemid 46763012)
11. Diella F, Gould CM, Chica C, Via A, Gibson TJ (2008) Phospho.ELM: a database of phosphorylation sites-update 2008. Nucleic Acids Res 36: D240-D244 (Pubitemid 351149729)
12. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868 (Pubitemid 37383716)
13. Fritsche-Guenther R, Witzel F, Sieber A, Herr R, Schmidt N, Braun S, Brummer T, Sers C, Bluthgen N (2011) Strong negative feedback from Erk to Raf confers robustness to MAPK signalling. Mol Syst Biol 7: 489
14. Gonzalez FA, Raden DL, Davis RJ (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 266: 22159-22163 (Pubitemid 21908629)
15. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B (2004) PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4: 1551-1561 (Pubitemid 38738314)
16. Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K (1999) Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 13: 163-175 (Pubitemid 29061947)
17. JochumW, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412 (Pubitemid 32531298)
18. Julien C, Coulombe P, Meloche S (2003) Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. J Biol Chem 278: 42615-42624 (Pubitemid 37310535)
19. Karin M, Liu Z, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246 (Pubitemid 27135992)
20. Kersey PJ, Duarte J, Williams A, Karavidopoulou Y, Birney E, Apweiler R (2004) The International Protein Index: an integrated database for proteomics experiments. Proteomics 4: 1985-1988 (Pubitemid 38880363)
21. Kosako H, Yamaguchi N, Aranami C, Ushiyama M, Kose S, Imamoto N, Taniguchi H, Nishida E, Hattori S (2009) Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporinmediated nuclear transport. Nat Struct Mol Biol 16: 1026-1035
22. Lawrence MC, Jivan A, Shao C, Duan L, Goad D, Zaganjor E, Osborne J, McGlynn K, Stippec S, Earnest S, Chen W, Cobb MH (2008) The roles of MAPKs in disease. Cell Res 18: 436-442 (Pubitemid 351498850)
23. Li B, Tournier C, Davis RJ, Flavell RA (1999) Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J 18: 420-432 (Pubitemid 29041950)
24. Marcantonio M, Trost M, Courcelles M, Desjardins M, Thibault P (2008) Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol Cell Proteomics 7: 645-660 (Pubitemid 351597477)
25. Mody N, Leitch J, Armstrong C, Dixon J, Cohen P (2001) Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 502: 21-24 (Pubitemid 32722053)
26. Nakabeppu Y, Ryder K, Nathans D (1988) DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 55: 907-915
27. Old WM, Shabb JB, Houel S, Wang H, Couts KL, Yen CY, Litman ES, Croy CH, Meyer-Arendt K, Miranda JG, Brown RA, Witze ES, Schweppe RE, Resing KA, Ahn NG (2009) Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell 34: 115-131
28. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, MannM (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648 (Pubitemid 44647421)
29. Pan C, Gnad F, Olsen JV, Mann M (2008) Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors. Proteomics 8: 4534-4546
30. Pan C, Olsen JV, Daub H, Mann M (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics 8: 2796-2808
31. Pearson G, Robinson F, Beers Gibson T, Xu BE, KarandikarM, Berman K, CobbMH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183 (Pubitemid 32458157)
32. Perez-Benavente B, Garcia JL, Rodriguez MS, Pineda-Lucena A, Piechaczyk M, Font de Mora J, Farras R (2012) GSK3- SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase. Oncogene 32: 2189-2199
33. Ramos JW(2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40: 2707-2719
34. Schubbert S, Shannon K, Bollag G (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295-308 (Pubitemid 46480970)
35. Servant MJ, Coulombe P, Turgeon B, Meloche S (2000) Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 148: 543-556
36. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136 (Pubitemid 34521026)
37. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, DeMaggio AJ, Hoekstra MF, Blenis J, Hunter T, Cantley LC (1996) A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol 16: 6486-6493 (Pubitemid 26361007)
38. Stamm S (2008) Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283: 1223-1227
39. Tanoue T, Adachi M, Moriguchi T, Nishida E (2000) A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2: 110-116
40. Tartaglia M, Gelb BD (2010) Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N YAcad Sci 1214: 99-121
41. Thingholm TE, Jorgensen TJ, Jensen ON, Larsen MR (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat Protoc 1: 1929-1935 (Pubitemid 46773313)
42. Trost M, English L, Lemieux S, Courcelles M, Desjardins M, Thibault P (2009) The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 30: 143-154
43. Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44 (Pubitemid 43108774)